Oxidative stress affecting the thyroxin biosynthesis might explain the proneness of patients with Down’s syndrome (DS) (trisomia 21) to develop hypothyroidism. Thyroideal cells are exposed to endogenous H2O2 that acts as a cofactor for the iodination of thyroxin precursors. The gland has high levels of selenium-containing proteins, including peroxide-detoxicating enzyme proteins. The object of the present study was to explore the hypothesis of a role of an imbalance between toxic oxygen production and protective metalloenzymes during the development of thyroid hypofunction in DS patients. We analyzed serum levels of thyroid hormones and trace metals in 38 institutionalized adults with DS, using mentally retarded subjects matched for age, sex, and behavioral function as controls. The DS patients had significantly lower mean values of free thyroxin (fT4) and increased TSH (thyroid stimulating hormone), as compared to the controls. They had lower serum selenium than the controls. A positive correlation was observed between serum concentrations of fT4 and selenium in the DS patients (r=0.393, p<0.05). No significant differences were found between the fT4 or the TSH concentrations in the patients with and without circulating antithyroid autoantibodies. Our results support the suggestion that thyroid hypofunction in patients with Down’s syndrome in some way is linked to the low serum levels of selenium found in these patients. It is suggested that selenium-containing proteins are involved in thyroid hormonal synthesis, by protecting biosynthetic processes against the toxicity of free oxygen radicals.
This is a preview of subscription content,to check access.
Access this article
Similar content being viewed by others
J. C. Murdock, W. A. Ratcliffe, B. G. McLary, J. C. Rodger, and J. G. Ratcliffe, Thyroid function in adults with Down’s syndrome, J. Clin. Endocrinol. Metab. 44, 453–458 (1977).
C. Baxter, R. C. Larkins, F. I. R. Martin, P. Heyma, K. Myles, and L. Ryan, Down’s syndrome and thyroid function in adults, Lancet 1975(II), 794 (1975).
C. E. Benda, The Child with Mongolism, Grune and Stratton, London, p. 110 (1960).
S. Korsager, Autoimmunitet ved Down’s syndrom, Ugeskr. Læger 143, 1589–1591 (1981).
D. Friedman, W. S. Pond, and D. R. O’Brian, Thyroid dysfunction in individuals with Down’s syndrome, Arch. Intern. Med. 149, 1990–1993 (1989).
J. Nève, L. Molle, M. Hanocq, P. M. Sinet, and R. VanGeffel, Erythrocyte and plasma trace element levels in clinical assessments. Biol. Trace Element Res. 5, 75–79 (1983).
R. Lefhem and M. Orrell, Antioxidants and dementia, Lancet 349, 1189 (1997).
J. Aaseth, H. Frey, E. Glattre, G. Norheim, J. Ringstad, and Y. Thomassen, Selenium concentrations in the human thyroid gland. Biol. Trace Element Res. 24, 147–152 (1989).
D. Behne, C. Weiss-Nowak, M. Kalchlsch, C. Westphal, H. Gessner, and A. Kyriakopoulos, Studies on the distribution and characteristics of new mammalian selenium-containing proteins, Analyst 120, 823–825 (1995).
P. Goyens, J. Golstein, B. Nsombola, H. Vis, and J. E. Dumont, Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism. Acta Endocrinol. (Copenh.) 114, 503–508 (1987).
J. Aaseth, J. Alexander, Y. Thomassen, J. P. Blomhoff, and S. Skrede, Serum selenium levels in liver diseases, Clin. Biochem. 15, 281–283 (1982).
A. Aakvaag, T. Sand, P. K. Opstad, and F. Fonnum, Hormonal changes in serum in young men during prolonged physical strain, Eur. J. Appl. Physiol. 39, 283–291 (1978).
G. W. Snedecor and W. G. Cochran, Statistical Methods, 6th ed. Iowa State University Press, Ames, p. 175 (1974).
J. Neve, P. M. Sinet, L. Molle, and A. Nicole, Selenium, zinc and copper in Down’s syndrome (trisomy 21): blood levels and relation with glutathione peroxidase and superoxide dismutase, Clin. Chim. Acta 133, 209–214 (1983).
B. Bjørksten, K. Back, H. Gustavson, B. Hallmans, B. Haggløf, and A. Tarnvik, Zinc and immune function in Down’s syndrome. Acta Pædiatr. Scand. 69, 183–187 (1980).
F. Vertongen, P. Cauchie, and D. Gnat, Selenium and glutathione peroxidase in plasma and erythrocytes of Down’s syndrome (trisomy 21) patients, J. Ment. Defic. Res. 28, 261–268 (1984).
Ø. J. Kanavin, H. Scott, O. Fausa, J. Ek, P. I. Gaarder, and P. Brandtzaeg, Immunological studies in Down’s syndrome—measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels, Acta Med. Scand. 224, 473–477 (1988).
C. Williams, H. Quinn, E. Wright, P. E. Sylvester, P. H. Gossling, and J. W. T. Dickerson, Xylose absorption in Down’s syndrome, J. Ment. Defic. Res. 27, 173–177 (1985).
J. Kedziora, C. Bartosz, J. Gromadzinska, M. Sklodowska, W. Wesowicz, and J. Scianowski, Lipid peroxides in blood plasma and enzymatic antioxidative defence of erythrocytes in Down’s syndrome, Clin. Chim. Acta 154, 191–194 (1986).
N. Crosti, J. Bajer, A. Serra, A. Rigo, M. Scarpa, and P. Viglino, Coordinate expression of Mn-containing superoxide dismutase in human fibroblasts with trisomy 21, J. Cell. Sci. 79, 95–103 (1985).
G. Anneren, M. Gebre-Mehdin, K. H. Gustavson, and L. O. Plantin, Selenium in plasma and erythocytes in patients with Down’s syndrome and healthy controls. Variation in relation to age, sex and glutathione peroxidase activity in erythrocytes, Acta Pœdiatr. Scand. 74, 508–514 (1985).
P. M. Sinet, Metabolism of oxygen derivatives in Down’s syndrome, Ann. NY Acad. Sci. 396, 83–84 (1982).
F. Carmignol, P. M. Sinet, and H. Jerome, Selenium dependent and non selenium dependent glutathione peroxidase in human tissue extracts, Biochim. Biophys. Acta 759, 49 (1983).
B. Smith and R. Hall, Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Grave’s disease, Clin. Endocrinol. 11, 437–444 (1979).
A. W. C. Kung, K. K. Pun, K. S. L. Lam, P. Choi, C. Wang, and R. T. T. Yeung, Long term results following 131I treatment for Grave’s disease, Q. J. Med. 76, 961–967 (1990).
T. Bjøro, T. Schreiner, J. Holmen, K. Midthjell, Ø. Kruger, and H. Brochmann, Frequency of thyroid diseases and dysfunction in Nord-Trøndelag, a county in Mid-Norway, J. Endocrin. Invest. 22(6)(Suppl.), 118 (1999).
About this article
Cite this article
Kanavin, Ø.J., Aaseth, J. & Birketvedt, G.S. Thyroid hypofunction in Down’s syndrome. Biol Trace Elem Res 78, 35–42 (2000). https://doi.org/10.1385/BTER:78:1-3:35